Assignee
RECURIUM IP HOLDINGS LLC
US·25 granted patents·37 pending applications·20 citations·filing 2016–2025
Top patents by PatentIndex Score
62 records- 0196US11813260B1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Granted Nov 14, 2023·1 cites·20 claims
- 0295US11339162B1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0393US11813259B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Nov 14, 2023·1 cites·17 claims
- 0491US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0589US2024180899A1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 0687US11590126B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Feb 28, 2023·1 cites·97 claims
- 0787US11344546B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 31, 2022·1 cites·109 claims
- 0883US11065234B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·1 cites·32 claims
- 0982US11098030B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Aug 24, 2021·1 cites·13 claims
- 1082US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 1181US11278532B2Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 22, 2022·1 cites·22 claims
- 1280US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1379US11124518B2L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Sep 21, 2021·2 cites·22 claims
- 1479US2026028363A1Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 1576US10793504B2Methods for cross couplingRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Oct 6, 2020·1 cites·22 claims
- 1674US11318134B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 3, 2022·0 cites·82 claims
- 1773US12049460B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted Jul 30, 2024·0 cites·20 claims
- 1873US2021330651A1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1972US10959989B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 30, 2021·0 cites·3 claims
- 2071US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 2170US11999728B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 2270US11065233B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·0 cites·24 claims
- 2369USRE50643EBenzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Oct 21, 2025·0 cites·100 claims
- 2469US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2566US12410204B2Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Sep 9, 2025·0 cites·19 claims
- 2666US11724971B2Process for making [1.1.1]propellaneRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Aug 15, 2023·0 cites·21 claims
- 2766US2024261295A1Combinations of wee1 inhibitors and anti-cd47 antibodiesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 2864US2024299395A1Combination therapies comprising wee1 inhibitors and dna damage response (ddr) inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 2964US2024325397A1Use of combination therapy for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3063US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3163US2024325412A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3263US2024335447A1Wee1 inhibitor for cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3362US2021317124A11,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3462US2021115058A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3561US2024408097A1Wee1 inhibitors and methods for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 3661US2022125769A1Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 3760US10934304B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Mar 2, 2021·0 cites·23 claims
- 3858US2024197743A1Wee1 compound for treating uterine serous carcinomaRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 3956US2023167105A1Bcl-2 protein inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4056US2023381172A1Combinations of bcl-2 inhibitors with chemotherapeutic agentsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4154US10653681B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted May 19, 2020·0 cites·12 claims
- 4254US2023210854A1Mono- and combination therapiesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4354US2023234956A1Methods of making wee1 inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4454US2023159416A1Difluoromethyl iodo compounds and methodsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4554US2023158048A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4653US11339103B2Continuous flow processes for making bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted May 24, 2022·0 cites·31 claims
- 4753US2023065577A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 4853US2023212118A1Preparation of an selective estrogen receptor degraderRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4952US2022265834A1Bcl-2 protein inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 5052US2023054854A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when RECURIUM IP HOLDINGS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →